ACXP
Price:
$0.858
Market Cap:
$14.49M
Acurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections. Its lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that has completed Phase II clinical trial to treat patients with clostridium difficile infections. The company is also developing ACX-375C, a potential oral and parenteral treatment targeting gram-positive bacteria, including methicillin-resistant staphylococcus aureus, vancomycin-resistant enterococcus, and penicillin-resistant streptococcus pneumoniae. Acurx Pharmaceuticals, Inc. was incorporated in 2017 and is headquartered in Staten Island, New York.[Read more]
Industry
Biotechnology
IPO Date
2021-06-25
Stock Exchange
NASDAQ
Ticker
ACXP
According to Acurx Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current PE Ratio is -0.79. This represents a change of -52.06% compared to the average of -1.65 of the last 4 quarters.
The mean historical PE Ratio of Acurx Pharmaceuticals, Inc. over the last ten years is -8.11. The current -0.79 PE Ratio has changed 873.63% with respect to the historical average. Over the past ten years (40 quarters), ACXP's PE Ratio was at its highest in in the December 2022 quarter at 5.68. The PE Ratio was at its lowest in in the June 2020 quarter at -20.61.
Average
-8.11
Median
-3.56
Minimum
-17.01
Maximum
-3.33
Discovering the peaks and valleys of Acurx Pharmaceuticals, Inc. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 28.94%
Maximum Annual PE Ratio = -3.33
Minimum Annual Increase = -79.53%
Minimum Annual PE Ratio = -17.01
Year | PE Ratio | Change |
---|---|---|
2023 | -3.33 | -6.49% |
2022 | -3.56 | 2.27% |
2021 | -3.48 | -79.53% |
2020 | -17.01 | 28.94% |
The current PE Ratio of Acurx Pharmaceuticals, Inc. (ACXP) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-3.46
5-year avg
-8.11
10-year avg
-8.11
Acurx Pharmaceuticals, Inc.’s PE Ratio is greater than Aerovate Therapeutics, Inc. (-0.88), greater than Adagene Inc. (-2.61), greater than Acrivon Therapeutics, Inc. Common Stock (-3.01), greater than Rezolute, Inc. (-4.43), less than AN2 Therapeutics, Inc. (-0.67), greater than Anebulo Pharmaceuticals, Inc. (-4.62), greater than Mineralys Therapeutics, Inc. (-4.08), greater than Silo Pharma, Inc. (-1.04), less than Protagenic Therapeutics, Inc. (-0.37), greater than Lumos Pharma, Inc. (-1.04), greater than Candel Therapeutics, Inc. (-5.42), greater than PMV Pharmaceuticals, Inc. (-1.49), less than Monopar Therapeutics Inc. (-0.66), greater than Enochian Biosciences, Inc. (-1.56),
Company | PE Ratio | Market cap |
---|---|---|
-0.88 | $74.35M | |
-2.61 | $83.89M | |
-3.01 | $189.08M | |
-4.43 | $255.24M | |
-0.67 | $40.78M | |
-4.62 | $36.57M | |
-4.08 | $624.85M | |
-1.04 | $4.10M | |
-0.37 | $2.91M | |
-1.04 | $37.54M | |
-5.42 | $392.72M | |
-1.49 | $76.84M | |
-0.66 | $128.83M | |
-1.56 | $45.38M |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Acurx Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Acurx Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Acurx Pharmaceuticals, Inc.'s PE Ratio?
How is the PE Ratio calculated for Acurx Pharmaceuticals, Inc. (ACXP)?
What is the highest PE Ratio for Acurx Pharmaceuticals, Inc. (ACXP)?
What is the 3-year average PE Ratio for Acurx Pharmaceuticals, Inc. (ACXP)?
What is the 5-year average PE Ratio for Acurx Pharmaceuticals, Inc. (ACXP)?
How does the current PE Ratio for Acurx Pharmaceuticals, Inc. (ACXP) compare to its historical average?